• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Hempacco Receives Notification of Deficiency from Nasdaq

    5/31/24 4:12:00 PM ET
    $HPCO
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $HPCO alert in real time by email

    San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").

    The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission. The Notice has no immediate effect on the listing or trading of the Company's securities. However, if the Company fails to timely regain compliance with the Rule, the Company's securities will be subject to delisting from Nasdaq. Under the Notice, the Company has until June 17, 2024, to submit an update to its plan to regain compliance with the Rule. If Nasdaq accepts the Company's plan, then Nasdaq may grant an exception of up to 180 calendar days from the initial filing delinquency date, until October 14, 2024, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company's plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company's plan, then the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.

    The Company is working diligently to complete and file the Quarterly Report and regain compliance with the Rule.

    About Hempacco

    Hempacco Co., Inc.'s goal is Disrupting Tobacco's™ nearly $1 trillion industry with herb and hemp-based alternatives to nicotine cigarettes by manufacturing and marketing herb, spice, and cannabinoid smokables and rolling paper. Hempacco owns The Real Stuff™ functional hemp cigarette and rolling paper brand.

    Safe Harbor Statement

    This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes," "plans," "projected," "predicts," "potential," or "hopes" or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: (i) potential failure to meet projected development and related targets; (ii) changes in applicable laws or regulations that may impact our products and business; (iii) the effect of geopolitical and economic conditions on the Company and its current or intended markets; and (iv) other risks and uncertainties described herein, as well as those risks and uncertainties discussed from time to time in other reports and other public filings with the Securities and Exchange Commission (the "SEC") by the Company. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur.

    Corporate Logo

    To view the source version of this press release, please visit https://www.newsfilecorp.com/release/211310

    Get the next $HPCO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $HPCO

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $HPCO
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Hempacco Receives Notification of Deficiency from Nasdaq

      San Diego, California--(Newsfile Corp. - May 31, 2024) - Hempacco Co., Inc. (NASDAQ:HPCO) ("Hempacco" or the "Company"), a vertically integrated hemp manufacturing company, announced today that on May 23, 2024, it received a written notice (the "Notice") from the Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") indicating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the "Rule") because the Company has not yet filed its Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024 (the "Quarterly Report").The Rule requires listed companies to timely file all required periodic reports with the Securities and Exchange Commission.

      5/31/24 4:12:00 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street Airs Episode 572 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network, Monday, May 6, 2024, at 10:30 PM PT

      NEW YORK, May 06, 2024 (GLOBE NEWSWIRE) -- FMW Media Works Corp.'s New to the Street, a nationally broadcasted business television production, announces airing Episode 572 on the FOX Business Network on Monday, May 6, 2024, at 10:30 PM PT. New to The Street's Episode 572 line-up features the following Five (5) Corporate interviews: 1). Labor Relations Firm - Greer Consulting, Inc.'s (GCI) interview with Jason Greer, Founder/CEO. 2). New to The Street's "Game Changers" with TV Host Ana Berry talking with Jorge Olson, Chief Marketing Officer (CMO), Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) and Brad Wyatt, Chief Executive Officer, Illumination Brands, Inc. 3). Digital Marketing- Banzai Int

      5/6/24 9:30:00 AM ET
      $BNZI
      $HPCO
      $LRHC
      Computer Software: Prepackaged Software
      Technology
      Medicinal Chemicals and Botanical Products
      Health Care
    • New to The Street and Hempacco Co., Inc. Sign Three Month Media Contract

      NEW YORK, March 28, 2024 (GLOBE NEWSWIRE) -- New to The Street and Hempacco Co., Inc. (NASDAQ:HPCO) ($HPCO) ("Hempacco") signed a three-month media contract. The agreement calls for the continuation of filming and broadcasting tailored interviews and streaming digital billboard aids in New York City. The contract calls for the New to the Street's TV news host to interview key corporate representatives from Hempacco Co., Inc. Each week over the next three months, New to The Street's Hempacco interviews will air on the FOX Business Network as sponsored programming. New to The Street's TV hosts will provide in-depth interviews with HPCO's management team with focused discuss

      3/28/24 9:15:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Leadership Updates

    Live Leadership Updates

    See more
    • Hempacco Announces Opening of European Office as Part of International Expansion Strategy

      Jakub Duda appointed Country Manager of Hempacco EuropeSan Diego, California--(Newsfile Corp. - April 4, 2023) - Hempacco Co, Inc. (NASDAQ:HPCO) ("Hempacco"), a hemp smokables company Disrupting Tobacco's™ nearly $1 Trillion industry with hemp cigarettes, smoking paper, and alternatives to nicotine tobacco, today announced the opening of its European office as part of its international expansion strategy. Hempacco Europe, SP. Z O.O., located in Warsaw, Poland, will be the company's new European subsidiary.This follows the company's appointment of Jakub Duda as Country Manager of Hempacco Europe. Jakub is a creative Business Development Manager with over ten years of experience leading intern

      4/4/23 9:00:00 AM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Titus Stuart W

      4 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:54 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • SEC Form 3: New insider Titus Stuart W claimed ownership of 100,000 shares

      3 - Hempacco Co., Inc. (0001892480) (Issuer)

      5/31/23 4:24:18 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care

    $HPCO
    SEC Filings

    See more
    • Hempacco Co. Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      10/10/24 5:00:29 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      9/9/24 12:45:38 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care
    • Hempacco Co. Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

      8-K - Hempacco Co., Inc. (0001892480) (Filer)

      8/23/24 4:51:27 PM ET
      $HPCO
      Medicinal Chemicals and Botanical Products
      Health Care